Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

MDRR vs PSTV vs GOOD vs NRXP vs PINE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MDRR
Medalist Diversified REIT, Inc.

REIT - Diversified

Real EstateNASDAQ • US
Market Cap$12M
5Y Perf.-62.1%
PSTV
Plus Therapeutics, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$14M
5Y Perf.-99.0%
GOOD
Gladstone Commercial Corporation

REIT - Diversified

Real EstateNASDAQ • US
Market Cap$616M
5Y Perf.-29.0%
NRXP
NRx Pharmaceuticals, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$85M
5Y Perf.-97.2%
PINE
Alpine Income Property Trust, Inc.

REIT - Retail

Real EstateNYSE • US
Market Cap$281M
5Y Perf.+58.8%

MDRR vs PSTV vs GOOD vs NRXP vs PINE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MDRR logoMDRR
PSTV logoPSTV
GOOD logoGOOD
NRXP logoNRXP
PINE logoPINE
IndustryREIT - DiversifiedBiotechnologyREIT - DiversifiedBiotechnologyREIT - Retail
Market Cap$12M$14M$616M$85M$281M
Revenue (TTM)$10M$5M$166M$242K$65M
Net Income (TTM)$-2M$-22M$21M$-38M$-415K
Gross Margin91.5%-11.7%59.5%-4.1%
Operating Margin5.3%-293.5%27.9%-63.0%28.0%
Forward P/E83.0x59.3x
Total Debt$785K$821K$856M$631K$394M
Cash & Equiv.$3M$9M$11M$8M$5M

MDRR vs PSTV vs GOOD vs NRXP vs PINELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MDRR
PSTV
GOOD
NRXP
PINE
StockMay 20May 26Return
Medalist Diversifie… (MDRR)10037.9-62.1%
Plus Therapeutics, … (PSTV)1001.0-99.0%
Gladstone Commercia… (GOOD)10071.0-29.0%
NRx Pharmaceuticals… (NRXP)1002.8-97.2%
Alpine Income Prope… (PINE)100158.8+58.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: MDRR vs PSTV vs GOOD vs NRXP vs PINE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GOOD leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. NRx Pharmaceuticals, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. PINE also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
MDRR
Medalist Diversified REIT, Inc.
The REIT Holding

MDRR lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: real estate exposure
PSTV
Plus Therapeutics, Inc.
The Healthcare Pick

Among these 5 stocks, PSTV doesn't own a clear edge in any measured category.

Best for: healthcare exposure
GOOD
Gladstone Commercial Corporation
The Real Estate Income Play

GOOD carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 0 yrs, beta 0.55, yield 11.4%
  • 51.0% 10Y total return vs PINE's 38.3%
  • Beta 0.55, yield 11.4%, current ratio 1.63x
  • 12.7% margin vs NRXP's -157.3%
Best for: income & stability and long-term compounding
NRXP
NRx Pharmaceuticals, Inc.
The Growth Leader

NRXP is the #2 pick in this set and the best alternative if growth and momentum is your priority.

  • 101.1% revenue growth vs PSTV's -10.5%
  • +55.3% vs PSTV's -57.8%
Best for: growth and momentum
PINE
Alpine Income Property Trust, Inc.
The Real Estate Income Play

PINE ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.

  • Rev growth 15.9%, EPS growth -257.1%, 3Y rev CAGR 10.2%
  • Lower volatility, beta 0.33, current ratio 0.33x
  • Better valuation composite
  • Beta 0.33 vs NRXP's 1.91
Best for: growth exposure and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthNRXP logoNRXP101.1% revenue growth vs PSTV's -10.5%
ValuePINE logoPINEBetter valuation composite
Quality / MarginsGOOD logoGOOD12.7% margin vs NRXP's -157.3%
Stability / SafetyPINE logoPINEBeta 0.33 vs NRXP's 1.91
DividendsGOOD logoGOOD11.4% yield, vs MDRR's 4.3%, (2 stocks pay no dividend)
Momentum (1Y)NRXP logoNRXP+55.3% vs PSTV's -57.8%
Efficiency (ROA)GOOD logoGOOD1.7% ROA vs NRXP's -489.9%

MDRR vs PSTV vs GOOD vs NRXP vs PINE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MDRRMedalist Diversified REIT, Inc.
FY 2025
Retail center properties
69.1%$6M
Flex center property
30.9%$3M
PSTVPlus Therapeutics, Inc.
FY 2022
Grant
100.0%$224,000
GOODGladstone Commercial Corporation

Segment breakdown not available.

NRXPNRx Pharmaceuticals, Inc.
FY 2025
Therapy
100.0%$854,000
PINEAlpine Income Property Trust, Inc.
FY 2025
Income Properties
100.0%$49M

MDRR vs PSTV vs GOOD vs NRXP vs PINE — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGOODLAGGINGNRXP

Income & Cash Flow (Last 12 Months)

GOOD leads this category, winning 3 of 6 comparable metrics.

GOOD is the larger business by revenue, generating $166M annually — 684.9x NRXP's $242,000. GOOD is the more profitable business, keeping 12.7% of every revenue dollar as net income compared to NRXP's -157.3%. On growth, PINE holds the edge at +29.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMDRR logoMDRRMedalist Diversif…PSTV logoPSTVPlus Therapeutics…GOOD logoGOODGladstone Commerc…NRXP logoNRXPNRx Pharmaceutica…PINE logoPINEAlpine Income Pro…
RevenueTrailing 12 months$10M$5M$166M$242,000$65M
EBITDAEarnings before interest/tax$4M-$15M$106M-$31M$45M
Net IncomeAfter-tax profit-$2M-$22M$21M-$38M-$415,000
Free Cash FlowCash after capex$12,992-$21M$90M-$12M-$46M
Gross MarginGross profit ÷ Revenue+91.5%-11.7%+59.5%-4.1%
Operating MarginEBIT ÷ Revenue+5.3%-2.9%+27.9%-63.0%+28.0%
Net MarginNet income ÷ Revenue-23.0%-4.3%+12.7%-157.3%-0.6%
FCF MarginFCF ÷ Revenue+0.1%-4.0%+54.1%-49.0%-71.7%
Rev. Growth (YoY)Latest quarter vs prior year+11.8%-3.2%+11.8%+29.6%
EPS Growth (YoY)Latest quarter vs prior year-96.0%+100.0%+2.8%-80.0%+185.7%
GOOD leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

MDRR leads this category, winning 3 of 6 comparable metrics.

On an enterprise value basis, MDRR's 2.7x EV/EBITDA is more attractive than PINE's 14.6x.

MetricMDRR logoMDRRMedalist Diversif…PSTV logoPSTVPlus Therapeutics…GOOD logoGOODGladstone Commerc…NRXP logoNRXPNRx Pharmaceutica…PINE logoPINEAlpine Income Pro…
Market CapShares × price$12M$14M$616M$85M$281M
Enterprise ValueMkt cap + debt − cash$11M$6M$1.5B$78M$671M
Trailing P/EPrice ÷ TTM EPS-5.87x-0.83x31.02x-2.28x-89.27x
Forward P/EPrice ÷ next-FY EPS est.82.97x59.32x
PEG RatioP/E ÷ EPS growth rate0.88x
EV / EBITDAEnterprise value multiple2.70x12.36x14.63x
Price / SalesMarket cap ÷ Revenue1.19x2.76x3.82x69.15x4.65x
Price / BookPrice ÷ Book value/share0.58x4.63x1.76x1.01x
Price / FCFMarket cap ÷ FCF160.75x9.17x
MDRR leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

GOOD leads this category, winning 5 of 9 comparable metrics.

GOOD delivers a 9.7% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-6 for PSTV. MDRR carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to GOOD's 2.50x. On the Piotroski fundamental quality scale (0–9), NRXP scores 5/9 vs PINE's 2/9, reflecting solid financial health.

MetricMDRR logoMDRRMedalist Diversif…PSTV logoPSTVPlus Therapeutics…GOOD logoGOODGladstone Commerc…NRXP logoNRXPNRx Pharmaceutica…PINE logoPINEAlpine Income Pro…
ROE (TTM)Return on equity-9.5%-5.6%+9.7%-0.1%
ROA (TTM)Return on assets-2.9%-156.0%+1.7%-4.9%-0.1%
ROICReturn on invested capital+0.9%+4.4%+2.2%
ROCEReturn on capital employed+0.7%-3.8%+5.3%+2.8%
Piotroski ScoreFundamental quality 0–944452
Debt / EquityFinancial leverage0.03x0.21x2.50x1.31x
Net DebtTotal debt minus cash-$2M-$8M$846M-$7M$390M
Cash & Equiv.Liquid assets$3M$9M$11M$8M$5M
Total DebtShort + long-term debt$784,987$821,000$856M$631,000$394M
Interest CoverageEBIT ÷ Interest expense0.21x-4.07x1.46x-24.18x0.82x
GOOD leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

PINE leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in PINE five years ago would be worth $14,124 today (with dividends reinvested), compared to $73 for PSTV. Over the past 12 months, NRXP leads with a +55.3% total return vs PSTV's -57.8%. The 3-year compound annual growth rate (CAGR) favors PINE at 13.6% vs PSTV's -61.6% — a key indicator of consistent wealth creation.

MetricMDRR logoMDRRMedalist Diversif…PSTV logoPSTVPlus Therapeutics…GOOD logoGOODGladstone Commerc…NRXP logoNRXPNRx Pharmaceutica…PINE logoPINEAlpine Income Pro…
YTD ReturnYear-to-date-9.0%-57.1%+21.6%+16.8%+18.8%
1-Year ReturnPast 12 months+0.1%-57.8%+0.7%+55.3%+37.3%
3-Year ReturnCumulative with dividends-2.3%-94.3%+43.8%-50.6%+46.6%
5-Year ReturnCumulative with dividends-36.1%-99.3%-9.7%-99.1%+41.2%
10-Year ReturnCumulative with dividends-80.2%-100.0%+51.0%-96.8%+38.3%
CAGR (3Y)Annualised 3-year return-0.8%-61.6%+12.9%-21.0%+13.6%
PINE leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MDRR and PINE each lead in 1 of 2 comparable metrics.

MDRR is the less volatile stock with a -0.35 beta — it tends to amplify market swings less than NRXP's 1.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PINE currently trades 94.4% from its 52-week high vs PSTV's 25.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMDRR logoMDRRMedalist Diversif…PSTV logoPSTVPlus Therapeutics…GOOD logoGOODGladstone Commerc…NRXP logoNRXPNRx Pharmaceutica…PINE logoPINEAlpine Income Pro…
Beta (5Y)Sensitivity to S&P 500-0.35x1.82x0.55x1.91x0.33x
52-Week HighHighest price in past year$14.52$23.43$15.03$3.84$20.80
52-Week LowLowest price in past year$9.55$0.27$10.33$1.62$13.10
% of 52W HighCurrent price vs 52-week peak+76.8%+25.4%+84.6%+79.7%+94.4%
RSI (14)Momentum oscillator 0–10047.049.849.164.754.0
Avg Volume (50D)Average daily shares traded1K355K390K913K176K
Evenly matched — MDRR and PINE each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — PSTV and GOOD each lead in 1 of 2 comparable metrics.

Analyst consensus: GOOD as "Buy", PINE as "Buy". Consensus price targets imply 5.7% upside for PINE (target: $21) vs 2.2% for GOOD (target: $13). For income investors, GOOD offers the higher dividend yield at 11.35% vs PINE's 0.18%.

MetricMDRR logoMDRRMedalist Diversif…PSTV logoPSTVPlus Therapeutics…GOOD logoGOODGladstone Commerc…NRXP logoNRXPNRx Pharmaceutica…PINE logoPINEAlpine Income Pro…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$13.00$20.75
# AnalystsCovering analysts1412
Dividend YieldAnnual dividend ÷ price+4.3%+11.4%+0.2%
Dividend StreakConsecutive years of raises0100
Dividend / ShareAnnual DPS$0.48$1.44$0.04
Buyback YieldShare repurchases ÷ mkt cap+1.1%0.0%+0.7%0.0%+3.1%
Evenly matched — PSTV and GOOD each lead in 1 of 2 comparable metrics.
Key Takeaway

GOOD leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MDRR leads in 1 (Valuation Metrics). 2 tied.

Best OverallGladstone Commercial Corpor… (GOOD)Leads 2 of 6 categories
Loading custom metrics...

MDRR vs PSTV vs GOOD vs NRXP vs PINE: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is MDRR or PSTV or GOOD or NRXP or PINE a better buy right now?

For growth investors, Alpine Income Property Trust, Inc.

(PINE) is the stronger pick with 15. 9% revenue growth year-over-year, versus -10. 5% for Plus Therapeutics, Inc. (PSTV). Gladstone Commercial Corporation (GOOD) offers the better valuation at 31. 0x trailing P/E (83. 0x forward), making it the more compelling value choice. Analysts rate Gladstone Commercial Corporation (GOOD) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MDRR or PSTV or GOOD or NRXP or PINE?

On forward P/E, Alpine Income Property Trust, Inc.

is actually cheaper at 59. 3x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — MDRR or PSTV or GOOD or NRXP or PINE?

Over the past 5 years, Alpine Income Property Trust, Inc.

(PINE) delivered a total return of +41. 2%, compared to -99. 3% for Plus Therapeutics, Inc. (PSTV). Over 10 years, the gap is even starker: GOOD returned +51. 0% versus PSTV's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MDRR or PSTV or GOOD or NRXP or PINE?

By beta (market sensitivity over 5 years), Medalist Diversified REIT, Inc.

(MDRR) is the lower-risk stock at -0. 35β versus NRx Pharmaceuticals, Inc. 's 1. 91β — meaning NRXP is approximately -649% more volatile than MDRR relative to the S&P 500. On balance sheet safety, Medalist Diversified REIT, Inc. (MDRR) carries a lower debt/equity ratio of 3% versus 3% for Gladstone Commercial Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — MDRR or PSTV or GOOD or NRXP or PINE?

By revenue growth (latest reported year), Alpine Income Property Trust, Inc.

(PINE) is pulling ahead at 15. 9% versus -10. 5% for Plus Therapeutics, Inc. (PSTV). On earnings-per-share growth, the picture is similar: Plus Therapeutics, Inc. grew EPS 100. 0% year-over-year, compared to -79. 2% for Medalist Diversified REIT, Inc.. Over a 3-year CAGR, PSTV leads at 185. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MDRR or PSTV or GOOD or NRXP or PINE?

Gladstone Commercial Corporation (GOOD) is the more profitable company, earning 12.

0% net margin versus -23. 4% for NRx Pharmaceuticals, Inc. — meaning it keeps 12. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GOOD leads at 37. 2% versus -1324. 4% for NRXP. At the gross margin level — before operating expenses — PSTV leads at 91. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MDRR or PSTV or GOOD or NRXP or PINE more undervalued right now?

On forward earnings alone, Alpine Income Property Trust, Inc.

(PINE) trades at 59. 3x forward P/E versus 83. 0x for Gladstone Commercial Corporation — 23. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PINE: 5. 7% to $20. 75.

08

Which pays a better dividend — MDRR or PSTV or GOOD or NRXP or PINE?

In this comparison, GOOD (11.

4% yield), MDRR (4. 3% yield), PINE (0. 2% yield) pay a dividend. PSTV, NRXP do not pay a meaningful dividend and should not be held primarily for income.

09

Is MDRR or PSTV or GOOD or NRXP or PINE better for a retirement portfolio?

For long-horizon retirement investors, Medalist Diversified REIT, Inc.

(MDRR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 35), 4. 3% yield). NRx Pharmaceuticals, Inc. (NRXP) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MDRR: -80. 2%, NRXP: -96. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MDRR and PSTV and GOOD and NRXP and PINE?

These companies operate in different sectors (MDRR (Real Estate) and PSTV (Healthcare) and GOOD (Real Estate) and NRXP (Healthcare) and PINE (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MDRR is a small-cap income-oriented stock; PSTV is a small-cap quality compounder stock; GOOD is a small-cap income-oriented stock; NRXP is a small-cap quality compounder stock; PINE is a small-cap high-growth stock. MDRR, GOOD pay a dividend while PSTV, NRXP, PINE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

MDRR

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 1.7%
Run This Screen
Stocks Like

PSTV

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 54%
Run This Screen
Stocks Like

GOOD

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

NRXP

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 35%
Run This Screen
Stocks Like

PINE

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 14%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MDRR and PSTV and GOOD and NRXP and PINE on the metrics below

Revenue Growth>
%
(MDRR: 11.8% · PSTV: -3.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.